Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Takayasu Kurata

Showing results (1-10 of 129) with videos related to

Pageof 13
Sort By:
Expert Opinion on Drug Metabolism & Toxicology|February 26, 2009
Amrubicin for the treatment of advanced lung cancerTakayasu Kurata
Japanese Journal of Clinical Oncology|June 16, 2012
Efficacy and safety of denosumab for the treatment of bone metastases in patients with advanced cancerTakayasu Kurata, Kazuhiko Nakagawa
Clinical Medicine Insights. Oncology|June 23, 2011
Gemcitabine: efficacy in the treatment of advanced stage nonsquamous non-small cell lung cancerHidetoshi Hayashi, Takayasu Kurata, Kazuhiko Nakagawa
Nihon Geka Gakkai Zasshi|August 12, 2004
[Evidence-based practice guideline for unresectable advanced lung cancer in 2003]Masahiro Fukuoka, Takayasu Kurata, Nobuyuki Yamamoto
Investigational New Drugs|July 14, 2007
Amrubicin for non-small-cell lung cancer and small-cell lung cancerTakayasu Kurata, Isamu Okamoto, Kenji Tamura, et al.
Lung Cancer (Amsterdam, Netherlands)|April 25, 2007
Skeletal metastases in non-small cell lung cancer: a retrospective studyAsuka Tsuya, Takayasu Kurata, Kenji Tamura, et al.
Lung Cancer (Auckland, N.Z.)|August 18, 2017
New prognostic biomarkers and therapeutic effect of bevacizumab for patients with non-small-cell lung cancerMaiko Niki, Takashi Yokoi, Takayasu Kurata, et al.
Anticancer Research|July 11, 2006
A phase I study of irinotecan in combination with amrubicin for advanced lung cancer patientsHiroyasu Kaneda, Takayasu Kurata, Kenji Tamura, et al.
Lung Cancer (Amsterdam, Netherlands)|October 12, 2004
Retrospective analysis of the predictive factors associated with the response and survival benefit of gefitinib in patients with advanced non-small-cell lung cancerHiroyasu Kaneda, Kenji Tamura, Takayasu Kurata, et al.
Lung Cancer (Amsterdam, Netherlands)|September 26, 2006
Pemetrexed-induced edema of the eyelidTakayasu Kurata, Kenji Tamura, Isamu Okamoto, et al.
Pageof 13

Showing results (1-10 of 129) with videos related to

Sort By:
Pageof 13
Expert Opinion on Drug Metabolism & Toxicology|February 26, 2009
Amrubicin for the treatment of advanced lung cancerTakayasu Kurata
Japanese Journal of Clinical Oncology|June 16, 2012
Efficacy and safety of denosumab for the treatment of bone metastases in patients with advanced cancerTakayasu Kurata, Kazuhiko Nakagawa
Clinical Medicine Insights. Oncology|June 23, 2011
Gemcitabine: efficacy in the treatment of advanced stage nonsquamous non-small cell lung cancerHidetoshi Hayashi, Takayasu Kurata, Kazuhiko Nakagawa
Nihon Geka Gakkai Zasshi|August 12, 2004
[Evidence-based practice guideline for unresectable advanced lung cancer in 2003]Masahiro Fukuoka, Takayasu Kurata, Nobuyuki Yamamoto
Investigational New Drugs|July 14, 2007
Amrubicin for non-small-cell lung cancer and small-cell lung cancerTakayasu Kurata, Isamu Okamoto, Kenji Tamura, et al.
Lung Cancer (Amsterdam, Netherlands)|April 25, 2007
Skeletal metastases in non-small cell lung cancer: a retrospective studyAsuka Tsuya, Takayasu Kurata, Kenji Tamura, et al.
Lung Cancer (Auckland, N.Z.)|August 18, 2017
New prognostic biomarkers and therapeutic effect of bevacizumab for patients with non-small-cell lung cancerMaiko Niki, Takashi Yokoi, Takayasu Kurata, et al.
Anticancer Research|July 11, 2006
A phase I study of irinotecan in combination with amrubicin for advanced lung cancer patientsHiroyasu Kaneda, Takayasu Kurata, Kenji Tamura, et al.
Lung Cancer (Amsterdam, Netherlands)|October 12, 2004
Retrospective analysis of the predictive factors associated with the response and survival benefit of gefitinib in patients with advanced non-small-cell lung cancerHiroyasu Kaneda, Kenji Tamura, Takayasu Kurata, et al.
Lung Cancer (Amsterdam, Netherlands)|September 26, 2006
Pemetrexed-induced edema of the eyelidTakayasu Kurata, Kenji Tamura, Isamu Okamoto, et al.
Pageof 13